Patent · US Active

Antibody frameworks

US10174102B2 · kind B2 · utility

1Cited by

0References

12Claims

0Family size

Assignee

Numab Innovation AG · CH

Inventors

Sebastian Meyer · Bielefeld, DE
David Urech · Jona, CH

Key dates

Filing date	Jun 26, 2014
Grant date	Jan 8, 2019
Priority date	—
Expiry date	Jun 26, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to novel antibody frameworks with advantageous properties. For example, this invention relates to novel chimeric human antibody light chain frameworks, comprising framework regions I to III from Vκ and framework region IV from Vλ, with advantageous properties, such as high stability and reduced aggregation propensity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.